Precision Medicine: Where have we reached and where are we headed?

Sultan Qaboos Univ Med J. 2017 Aug;17(3):e255-e258. doi: 10.18295/squmj.2017.17.03.001. Epub 2017 Oct 10.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Evidence-Based Medicine / trends
  • Forecasting
  • Humans
  • Imatinib Mesylate / therapeutic use
  • Neoplasms / genetics
  • Neoplasms / therapy*
  • Precision Medicine / trends*
  • Rituximab / therapeutic use
  • Trastuzumab / therapeutic use

Substances

  • Antineoplastic Agents
  • Rituximab
  • Imatinib Mesylate
  • Trastuzumab